NCT00476138

Brief Summary

The present study attempts to evaluate the potential beneficial effects of a flavonoid, the epigallocatechingallate, on retinal ganglion cell function, evaluated by pattern electroretinogram, in subjects with ocular hypertension or early glaucoma.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Nov 2006

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2006

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 21, 2007

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2008

Completed
Last Updated

May 21, 2007

Status Verified

May 1, 2007

First QC Date

May 18, 2007

Last Update Submit

May 18, 2007

Conditions

Keywords

Epigallocatechin-GallateGlaucomaOptic NervePattern ElectroretinogramRetinal Ganglion Cells

Outcome Measures

Primary Outcomes (1)

  • PERG

    six months

Secondary Outcomes (2)

  • IOP

    six months

  • Optical Coherence Tomography measurements of retinal nerve fiber layer thickness

    six months

Interventions

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • IOP \> 21 mmHg at the time of diagnosis
  • Response to ipotensive therapy
  • No visible alterations of the optical nerve head (if OHT)
  • Visual field: normal (if OHT), \< -6dB at diagnosis (if POAG)
  • Alterations in PERG
  • Familiarity for glaucoma (if OHT)

You may not qualify if:

  • Change of ipotensive therapy
  • Ocular surgery
  • Other ocular pathologies
  • Smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catholic University, Policlinico A. Gemelli (Hospital)

Rome, 00168, Italy

RECRUITING

Related Publications (3)

  • Salgarello T, Colotto A, Falsini B, Buzzonetti L, Cesari L, Iarossi G, Scullica L. Correlation of pattern electroretinogram with optic disc cup shape in ocular hypertension. Invest Ophthalmol Vis Sci. 1999 Aug;40(9):1989-97.

    PMID: 10440253BACKGROUND
  • Colotto A, Falsini B, Salgarello T, Iarossi G, Galan ME, Scullica L. Photopic negative response of the human ERG: losses associated with glaucomatous damage. Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2205-11.

    PMID: 10892864BACKGROUND
  • Falsini B, Marangoni D, Salgarello T, Stifano G, Montrone L, Di Landro S, Guccione L, Balestrazzi E, Colotto A. Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram. Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1223-33. doi: 10.1007/s00417-009-1064-z. Epub 2009 Mar 17.

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionGlaucoma

Interventions

epigallocatechin gallate

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Benedetto Falsini, MD

    Chatolic University of Sacred Heart, Roma

    PRINCIPAL INVESTIGATOR
  • Tommaso Salgarello, M.D.

    Catholic University, Italy

    PRINCIPAL INVESTIGATOR
  • Dario Marangoni, M.D.

    Catholic University, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Benedetto Falsini, M.D.

CONTACT

Emilio Balestrazzi, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 18, 2007

First Posted

May 21, 2007

Study Start

November 1, 2006

Study Completion

July 1, 2008

Last Updated

May 21, 2007

Record last verified: 2007-05

Locations